Market Tracker

12/02 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.10
Delayed Data
As of Dec 02
 -0.11 / -4.98%
Today’s Change
2.06
Today|||52-Week Range
3.95
-40.68%
Year-to-Date
Here's Why PDL BioPharma Inc. Imploded and Fell 32% in November
Dec 02 / MotleyFool.com - Paid Partner Content
Why PDL BioPharma Inc. Is Down 14.8% Today
Nov 23 / MotleyFool.com - Paid Partner Content
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.21
Today’s open2.19
Day’s range2.06 - 2.24
Volume3,278,807
Average volume (3 months)1,959,091
Market cap$347.6M
Dividend yield9.53%
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.40%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.0
Price/Sales0.99
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
SELBSelecta Biosciences ...-0.80-3.92%
BOLDAudentes Therapeutic...+0.41+2.53%
BCRXBioCryst Pharmaceuti...+0.34+6.47%
VYGRVoyager Therapeutics...+0.50+3.84%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts